• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性不育的常规治疗。

The conventional management of male infertility.

机构信息

Center for Reproductive Medicine and Andrology, University of Münster, Germany; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.

出版信息

Int J Gynaecol Obstet. 2013 Dec;123 Suppl 2:S31-5. doi: 10.1016/j.ijgo.2013.09.001. Epub 2013 Sep 3.

DOI:10.1016/j.ijgo.2013.09.001
PMID:24079474
Abstract

Although the male reproductive function is impaired in about half of infertile couples, the evaluation of male infertility is underrated or neglected even today. In addition to a physical examination and imaging techniques, semen analysis as well as endocrine and genetic analyses should be part of the routine investigation. Few disorders have become subjects of rational treatment of the infertile male, even though, as examples, hypogonadotropic hypogonadism is treatable by gonadotropins and obstructive azoospermia by reconstructive surgery. Early treatment of maldescended testes and sexually transmitted diseases can prevent infertility. Similar pregnancy rates from patients with varicocele following surgery or counseling demonstrate the important role of the physician in the treatment of infertility. In the age of evidence-based medicine, most empirical treatments have been demonstrated to be ineffective. Instead, symptomatic treatment by assisted reproductive techniques has become a central tool to overcome otherwise untreatable male infertility.

摘要

尽管约有一半的不孕夫妇存在男性生殖功能障碍,但即使在今天,男性不育的评估也被低估或忽视了。除了体格检查和影像学技术外,精液分析以及内分泌和遗传分析也应该是常规检查的一部分。尽管例如促性腺激素可治疗低促性腺激素性性腺功能减退症,重建手术可治疗梗阻性无精子症,但很少有疾病成为理性治疗不孕男性的对象。早期治疗隐睾和性传播疾病可以预防不孕。精索静脉曲张手术后或咨询后的患者妊娠率相似,这表明医生在治疗不孕方面的重要作用。在循证医学时代,大多数经验性治疗已被证明无效。相反,通过辅助生殖技术进行对症治疗已成为克服其他无法治疗的男性不育症的重要手段。

相似文献

1
The conventional management of male infertility.男性不育的常规治疗。
Int J Gynaecol Obstet. 2013 Dec;123 Suppl 2:S31-5. doi: 10.1016/j.ijgo.2013.09.001. Epub 2013 Sep 3.
2
[Male infertility: recent developments].[男性不育症:最新进展]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Dec;56(12):1619-27. doi: 10.1007/s00103-013-1859-2.
3
Clinical review 100: Evaluation and treatment of the infertile couple.临床综述100:不孕夫妇的评估与治疗
J Clin Endocrinol Metab. 1998 Dec;83(12):4177-88. doi: 10.1210/jcem.83.12.5296.
4
Management of male-factor infertility.男性因素不孕的管理。
Best Pract Res Clin Obstet Gynaecol. 2012 Dec;26(6):769-75. doi: 10.1016/j.bpobgyn.2012.05.005. Epub 2012 Jun 16.
5
Experience with a comprehensive university hospital-based infertility program in Nigeria.尼日利亚一家综合性大学附属医院不孕不育项目的经验。
Int J Gynaecol Obstet. 2008 Apr;101(1):11-5. doi: 10.1016/j.ijgo.2007.09.034. Epub 2008 Feb 20.
6
Evaluation of male infertility.男性不育症的评估
Minerva Ginecol. 2009 Aug;61(4):261-83.
7
Male infertility in India: Demographics, aetiology and outcomes of standard clinical practice.印度男性不育症:标准临床实践的人口统计学、病因学和结果。
Natl Med J India. 2020 Nov-Dec;33(6):340-343. doi: 10.4103/0970-258X.321136.
8
Study of the causes and the results of treatment in infertile couples at Thammasat Hospital between 1999-2004.1999年至2004年期间在泰国国立法政大学医院对不孕夫妇的病因及治疗结果进行的研究。
J Med Assoc Thai. 2008 Jun;91(6):805-12.
9
Results of infertility investigations and follow-up among 312 infertile women and their partners in Kigali, Rwanda.卢旺达基加利312名不孕妇女及其伴侣的不孕症调查与随访结果。
Trop Doct. 2011 Apr;41(2):96-101. doi: 10.1258/td.2011.100410.
10
Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility.手术还是辅助生殖?男性不育治疗成本的决策分析。
J Urol. 2005 Nov;174(5):1926-31; discussion 1931. doi: 10.1097/01.ju.0000176736.74328.1a.

引用本文的文献

1
Effectiveness of recombinant follicle-stimulating hormone treatment in patients with oligo-asthenospermia at different levels of DNA fragmentation index: A phase II clinical trial.重组促卵泡激素治疗不同DNA碎片化指数水平的少弱精子症患者的有效性:一项II期临床试验。
Curr Urol. 2025 May;19(3):208-211. doi: 10.1097/CU9.0000000000000260. Epub 2024 Oct 22.
2
Differentiating between obstructive and non-obstructive azoospermia: A machine learning-based approach.梗阻性与非梗阻性无精子症的鉴别:一种基于机器学习的方法。
BJUI Compass. 2025 Feb 17;6(2):e493. doi: 10.1002/bco2.493. eCollection 2025 Feb.
3
Empirical Treatments for Male Infertility: A Focus on Lifestyle Modifications and Medicines.
男性不育的经验性治疗:聚焦生活方式调整与药物治疗
Diseases. 2024 Sep 11;12(9):209. doi: 10.3390/diseases12090209.
4
Human Sperm as an In Vitro Model to Assess the Efficacy of Antioxidant Supplements during Sperm Handling: A Narrative Review.人类精子作为评估精子处理过程中抗氧化补充剂功效的体外模型:一项叙述性综述。
Antioxidants (Basel). 2023 May 15;12(5):1098. doi: 10.3390/antiox12051098.
5
Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes.男性因素不孕与辅助生殖技术:适应证、微创准入标准与结局。
J Endocrinol Invest. 2023 Jun;46(6):1079-1085. doi: 10.1007/s40618-022-02000-4. Epub 2023 Jan 12.
6
Evaluation of Azoospermic Patients to Distinguish Obstructive from Non-Obstructive Azoospermia, and Necessity of Diagnostic Testis Biopsy: A Retrospective Study.无精子症患者区分梗阻性与非梗阻性无精子症的评估及诊断性睾丸活检的必要性:一项回顾性研究
Int J Fertil Steril. 2022 Aug 21;16(3):156-161. doi: 10.22074/ijfs.2021.532258.1140.
7
Severe male factor in fertilization: definition, prevalence, and treatment. An update.严重的男性受精因素:定义、流行率和治疗。更新。
Asian J Androl. 2022 Mar-Apr;24(2):125-134. doi: 10.4103/aja.aja_53_21.
8
Stem cell-based therapies for fertility preservation in males: Current status and future prospects.基于干细胞的男性生育力保存疗法:现状与未来展望。
World J Stem Cells. 2020 Oct 26;12(10):1097-1112. doi: 10.4252/wjsc.v12.i10.1097.
9
Multi-Target Tracking of Human Spermatozoa in Phase-Contrast Microscopy Image Sequences using a Hybrid Dynamic Bayesian Network.基于混合动态贝叶斯网络的相差显微镜图像序列中人精子的多目标跟踪。
Sci Rep. 2018 Mar 22;8(1):5068. doi: 10.1038/s41598-018-23435-x.
10
Tamoxifen is a potent antioxidant modulator for sperm quality in patients with idiopathic oligoasthenospermia.他莫昔芬是一种对特发性少弱精子症患者精子质量有强效作用的抗氧化调节剂。
Int Urol Nephrol. 2015 Sep;47(9):1463-9. doi: 10.1007/s11255-015-1065-2. Epub 2015 Jul 28.